NYSE:MET - Metlife Stock Price, News, & Analysis

Get Started

$39.23 -0.38 (-0.96 %)

(As of 12/12/2018 04:44 AM ET)

Previous Close$39.61

Today's Range$39.04 - $40.71

52-Week Range$38.90 - $55.21

Volume7.95 million shs

Average Volume6.23 million shs

Market Capitalization$40.10 billion

P/E Ratio8.72

Dividend Yield4.13%

Beta1.28

MetLife, Inc. engages in the insurance, annuities, employee benefits, and asset management businesses. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short- and long-term disability, individual disability, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and stable value products, including general and separate account guaranteed interest contracts, and private floating rate funding agreements. It also provides pension risk transfers, institutional income annuities, tort settlements, and capital markets investment products; and other products and services, such as life insurance products and funding agreements for funding postretirement benefits, as well as company, bank, or trust-owned life insurance used to finance nonqualified benefit programs for executives. In addition, the company offers automobile, homeowners', and personal excess liability, as well as small business owners' property, liability, and business interruption insurance products. Further, it provides fixed annuities and pension products; medical and credit insurance products; variable, universal, term, endowment, and whole life insurance products; variable, and fixed and indexed-linked annuities; and protection against costs of long-term health care services. MetLife, Inc. has a strategic alliance with Ernst & Young LLP. The company serves individuals, corporations and their employees, and other institutions through independent agents, property and casualty specialists, sales forces, sales teams and relationship managers, and other organizations, as well as through career agency, bancassurance, direct marketing, brokerage, and other third-party distribution and e-commerce channels. MetLife, Inc. was founded in 1863 and is headquartered in New York, New York.

Receive MET News and Ratings via Email

Sign-up to receive the latest news and ratings for MET and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NYSE

Industry Life insurance

Sub-IndustryLife & Health Insurance

SectorFinance

Current SymbolNYSE:MET

Previous Symbol

CUSIP59156R10

Webwww.metlife.com

Phone212-578-9500

Debt

Debt-to-Equity Ratio0.28

Current Ratio0.14

Quick Ratio0.14

Price-To-Earnings

Trailing P/E Ratio8.72

Forward P/E Ratio7.33

P/E Growth0.6

Sales & Book Value

Annual Sales$62.09 billion

Price / Sales0.62

Cash Flow$4.3205 per share

Price / Cash Flow9.08

Book Value$55.94 per share

Price / Book0.70

Profitability

EPS (Most Recent Fiscal Year)$4.50

Net Income$4.01 billion

Net Margins7.62%

Return on Equity9.76%

Return on Assets0.76%

Miscellaneous

Employees49,000

Outstanding Shares986,840,000

Market Cap$40.10 billion

OptionableOptionable

Metlife (NYSE:MET) Frequently Asked Questions

What is Metlife's stock symbol?

Metlife trades on the New York Stock Exchange (NYSE) under the ticker symbol "MET."

How often does Metlife pay dividends? What is the dividend yield for Metlife?

Metlife announced a quarterly dividend on Tuesday, October 23rd. Shareholders of record on Tuesday, November 6th will be paid a dividend of $0.42 per share on Thursday, December 13th. This represents a $1.68 annualized dividend and a yield of 4.28%. The ex-dividend date of this dividend is Monday, November 5th. View Metlife's Dividend History.

How will Metlife's stock buyback program work?

Metlife declared that its board has authorized a stock buyback program on Thursday, November 1st 2018, which authorizes the company to repurchase $2,000,000,000.00 in shares, according to EventVestor. This repurchase authorization authorizes the company to repurchase up to 4.6% of its shares through open market purchases. Shares repurchase programs are generally an indication that the company's board of directors believes its stock is undervalued.

How were Metlife's earnings last quarter?

Metlife Inc (NYSE:MET) issued its quarterly earnings data on Thursday, November, 1st. The financial services provider reported $1.38 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $1.27 by $0.11. The financial services provider had revenue of $16.40 billion for the quarter, compared to the consensus estimate of $15.88 billion. Metlife had a net margin of 7.62% and a return on equity of 9.76%. The business's quarterly revenue was down 2.2% compared to the same quarter last year. During the same quarter last year, the firm earned $1.09 EPS. View Metlife's Earnings History.

When is Metlife's next earnings date?

Metlife is scheduled to release their next quarterly earnings announcement on Tuesday, February 12th 2019. View Earnings Estimates for Metlife.

What price target have analysts set for MET?

12 brokers have issued 12 month target prices for Metlife's stock. Their forecasts range from $48.00 to $63.00. On average, they expect Metlife's stock price to reach $54.3636 in the next twelve months. This suggests a possible upside of 38.6% from the stock's current price. View Analyst Price Targets for Metlife.

What is the consensus analysts' recommendation for Metlife?

12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Metlife in the last year. There are currently 7 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Metlife.

What are Wall Street analysts saying about Metlife stock?

Here are some recent quotes from research analysts about Metlife stock:

1. According to Zacks Investment Research, "MetLife has been performing significantly well on the back of prudent underwriting and expense management. Its efforts to streamline business, only to focus on core business are really impressive. Its revenues grew in 2017 and first half of 2018 after declining for two years and the trend is likely to continue. Its strong international operations and disciplined capital management should drive long-term growth. However, the company’s exposure to catastrophe losses and investment in efficiency programs will put pressure on margins. Shares of the company have underperformed the industry in a year’s time. MetLife’s third quarter operating earnings of $1.38 per share beat the Zacks Consensus Estimate of $1.25 by 10.4%. The bottom line also surged 33% year over year on volume growth, favorable underwriting, expense management and an improved investment income. " (11/20/2018)
2. Wells Fargo & Co analysts commented, "We attended in Tokyo. The company provided context around its Asian business, which represents 25% of its earnings ($1.2 billion in 2017) but is expected to grow in the double-digits. Of its Asian business about 75% of its earnings comes from Japan. MET spoke optimistically about: (1) the growth prospects of the region due to its low insurance penetration, GDP growth of 4.8% in the countries MET operates in, and an aging population, and (2) its commitment to sustainable growth in cash from its Asian business (60% of its GAAP earnings are being taken out as dividends). The meeting also gave us a chance to hear from Kishore Ponnavolu, who took over as head of MET’s Asian business at the start of September. We are not changing our EPS estimates or price target at this time and do not expect a material movement in the shares following the meeting." (9/27/2018)

Has Metlife been receiving favorable news coverage?

Media stories about MET stock have been trending positive this week, according to InfoTrie. The research group scores the sentiment of press coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Metlife earned a media sentiment score of 2.6 on InfoTrie's scale. They also assigned media coverage about the financial services provider a news buzz of 3.0 out of 10, indicating that recent press coverage is unlikely to have an impact on the company's share price in the near future.

Who are some of Metlife's key competitors?

Some companies that are related to Metlife include China Life Insurance (LFC), AXA (AXAHY), Prudential Public (PUK), Prudential Financial (PRU), SWISS RE LTD/S (SSREY), Manulife Financial (MFC), Sun Life Financial (SLF), AVIVA PLC/ADR (AVVIY), HANNOVER RUECK/S (HVRRY), Lincoln National (LNC), AEGON (AEG), Torchmark (TMK), SONY Finl HOLDI/ADR (SNYFY), Scor (SCRYY) and Reinsurance Group of America (RGA).

Who are Metlife's key executives?

Metlife's management team includes the folowing people:

Mr. Steven Albert Kandarian, Chairman, Pres & CEO (Age 65)
Mr. Martin J. Lippert, Exec. VP and Head of Global Technology & Operations (Age 58)
Mr. Steven Jeffrey Goulart, Exec. VP & Chief Investment Officer (Age 59)
Mr. Michel A. Khalaf, Pres of U.S. Bus. & EMEA (Age 54)
Mr. John Dennis McCallion, Exec. VP & CFO (Age 44)

Who are Metlife's major shareholders?

Metlife's stock is owned by many different of retail and institutional investors. Top institutional investors include BlackRock Inc. (7.21%), Vanguard Group Inc. (6.72%), FMR LLC (5.28%), Dodge & Cox (4.68%), Massachusetts Financial Services Co. MA (2.37%) and Franklin Resources Inc. (2.07%). Company insiders that own Metlife stock include Christopher G Townsend, Gerald L Hassell, James M Kilts, Peter M Carlson and Steven A Kandarian. View Institutional Ownership Trends for Metlife.

Which major investors are selling Metlife stock?

MET stock was sold by a variety of institutional investors in the last quarter, including Franklin Resources Inc., Vanguard Group Inc., Sound Shore Management Inc. CT, Mitsubishi UFJ Trust & Banking Corp, Massachusetts Financial Services Co. MA, TD Asset Management Inc., American Century Companies Inc. and BlackRock Inc.. View Insider Buying and Selling for Metlife.

Which major investors are buying Metlife stock?

MET stock was acquired by a variety of institutional investors in the last quarter, including FMR LLC, Rehmann Capital Advisory Group, Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp, Prudential Financial Inc., Artemis Investment Management LLP, Los Angeles Capital Management & Equity Research Inc., Jennison Associates LLC and Clearbridge Investments LLC. Company insiders that have bought Metlife stock in the last two years include Gerald L Hassell and James M Kilts. View Insider Buying and Selling for Metlife.

How do I buy shares of Metlife?

Shares of MET can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Metlife's stock price today?

One share of MET stock can currently be purchased for approximately $39.23.

How big of a company is Metlife?

Metlife has a market capitalization of $40.10 billion and generates $62.09 billion in revenue each year. The financial services provider earns $4.01 billion in net income (profit) each year or $4.50 on an earnings per share basis. Metlife employs 49,000 workers across the globe.

What is Metlife's official website?

The official website for Metlife is http://www.metlife.com.

How can I contact Metlife?

Metlife's mailing address is 200 PARK AVENUE, NEW YORK NY, 10166. The financial services provider can be reached via phone at 212-578-9500.

MarketBeat Community Rating for Metlife (NYSE MET)

Community Ranking:		3.1 out of 5 ( )
Outperform Votes:		747 (Vote Outperform)
Underperform Votes:		465 (Vote Underperform)
Total Votes:		1,212

MarketBeat's community ratings are surveys of what our community members think about Metlife and other stocks. Vote "Outperform" if you believe MET will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MET will underperform the S&P 500 over the long term. You may vote once every thirty days.

This page was last updated on 12/12/2018 by MarketBeat.com Staff